Testing effectiveness (Phase 2)Ended earlyNCT05026736
What this trial is testing
Sintilimab for the Treatment of Locally Advanced, Metastatic, or Recurrent Angiosarcoma, the SiARa Cancer Study
Who this might be right for
Locally Advanced AngiosarcomaMetastatic AngiosarcomaRecurrent Angiosarcoma
M.D. Anderson Cancer Center 6